Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
批准号:
7687186
负责人:
GENHONG CHENG
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-17 至 2009-06-30
关键词:
AccountingAcetaminophenAcute Liver FailureAdenovirusesAgonistAmericasAntiviral AgentsAntiviral ResponseAspirinBiologicalCellsCellular Metabolic ProcessChemosensitizationChildDNA VirusesDataDiseaseGene TargetingGenesGoalsHepatocyteHepatotoxicityHormonesHost DefenseHumanIRF3 geneImmuneImmune responseInfectionInfluenzaInterferon Type IInvestigationKnockout MiceLeadMediatingMetabolic DiseasesMetabolic PathwayMetabolismMethodsMolecularMusNuclearNuclear Hormone ReceptorsNuclear Receptor GeneNuclear ReceptorsPathway interactionsPatientsPharmaceutical PreparationsRNARXRReceptor GeneRepressionRoleSignal PathwaySignaling MoleculeSyndromeTestingTissue TransplantationToll-like receptorsVesicular stomatitis Indiana virusViralViral PathogenesisVirusVirus Diseasescell typegene repressionhuman IRF3 proteinimmunoregulationinterferon regulatory factor-3mouse modelnovelnovel strategiespathogenpreventprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long term goal of this application is to greater elucidate the mechanisms and biological significance of
crosstalk between the innate immune response and nuclear hormone receptors in host defense against
infections and in pathogen-associated metabolic diseases. Preliminary data in our lab has identified a novel
Interferon Regulatory Factor 3(IRF3)-dependent but type I interferon independent pathway induced during
innate immune response to viral product stimulation or viral infection, which can lead to strong transcriptional
repression of Retinoid X Receptor a (RXRa). As RXRa is the major heterodimer partner for most of the
nuclear hormone receptors involved in numerous cellular metabolic processes, we hypothesize that repression
of RXRa and its regulated genes during viral infections can contribute to the pathogenesis of viral associated
metabolic diseases such as Reye¿s Syndrome, a hepatotoxicity disease that occurs when children are given
aspirin in the context of a viral infection. Furthermore, additional preliminary data in our lab showed that
nuclear hormone receptor agonists can suppress the induction of antiviral genes and promote viral replications.
We therefore also hypothesize that repression of nuclear hormone receptors by the innate immune response
may contribute to a proper anti-viral response. In this application, we will determine the roles and mechanisms
of the crosstalk between anti-viral immune response and nuclear hormone receptors in both viral associated
hepatotoxicity and host defense against viral infections. We plan to first develop mouse models that mimic
Reye¿s Syndrome and acetaminophen (APAP)-induced hepatotoxicity. We will then use these mouse models
to determine the molecular mechanisms responsible for hepatotoxicity resulting from the crosstalk between
anti-viral immune response and nuclear hormone receptors. Finally, we will analyze the effects of nuclear
hormone receptors and their agonists on anti-viral innate immune responses to determine if the repression of
nuclear hormone receptors by innate immune response is necessary for the proper host defense against viral
infections. We believe our investigation of the crosstalk between the innate immune response and nuclear
hormone receptor-mediated metabolism will not only help us to understand the mechanisms responsible for
viral induced metabolic diseases and drug induced immuno-suppressions but will also provide novel strategies
to prevent or treat patients with viral infections and their associated metabolic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
-
批准号:10222540
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:GENHONG CHENG
-
依托单位:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
-
批准号:10174522
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:GENHONG CHENG
-
依托单位:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
-
批准号:10461773
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2020
-
负责人:GENHONG CHENG
-
依托单位:
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV
-
批准号:10388193
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2018
-
负责人:GENHONG CHENG
-
依托单位:
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV
-
批准号:9925059
-
项目类别:
-
资助金额:$75.04万
-
财政年份:2018
-
负责人:GENHONG CHENG
-
依托单位:
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation
-
批准号:8039043
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2011
-
负责人:GENHONG CHENG
-
依托单位:
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation
-
批准号:8208992
-
项目类别:
-
资助金额:$18.69万
-
财政年份:2011
-
负责人:GENHONG CHENG
-
依托单位:
Mitiagrion of Radiation Damage by Mechanisms of Innate Immune Regulation
-
批准号:8011751
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2010
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:8091282
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:8481502
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:7741382
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:8282723
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
-
批准号:7868050
-
项目类别:
-
资助金额:$37.12万
-
财政年份:2009
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:7644341
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:7388575
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:8067083
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Regulation of Type 2 NF-kappaB Activation and Inflammation
-
批准号:7810716
-
项目类别:
-
资助金额:$28.0万
-
财政年份:2008
-
负责人:GENHONG CHENG
-
依托单位:
Viral Mediated Type I Interferon Induction
-
批准号:7587981
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2006
-
负责人:GENHONG CHENG
-
依托单位:
Viral Mediated Type I Interferon Induction
-
批准号:8636981
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2006
-
负责人:GENHONG CHENG
-
依托单位:
Viral Mediated Type I Interferon Induction
-
批准号:9458084
-
项目类别:
-
资助金额:$68.78万
-
财政年份:2006
-
负责人:GENHONG CHENG
-
依托单位:
国内基金
海外基金
SirT1在Acetaminophen诱发的药物性肝损伤中的作用及机制
-
批准号:81100281
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:黄卫锋
-
依托单位: